IL17A and asthma: This model vividly portrays the molecular events and pathophysiology such as infiltration of immune cells (eosinophils and neutrophils) and inflammatory mediators, reduction in levels of HDAC2, and increased cytokine IL-17 expression associated with steroid-resistant asthma [6–8].